Insulin resistance: an additional risk factor in the pathogenesis of cardiovascular disease in type 2 diabetes

scientific article

Insulin resistance: an additional risk factor in the pathogenesis of cardiovascular disease in type 2 diabetes is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S10741-015-9515-6
P698PubMed publication ID26542377

P2093author name stringSarita Gupta
Pawan K Singal
Ashim K Bagchi
Danielle da Silva Dias
Nathalia Bernardes
Gauri Akolkar
Komal Rawal
Tushar P Patel
P2860cites workActivation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylationQ22010150
Molecular mechanisms of insulin resistance in humans and their potential links with mitochondrial dysfunctionQ24632414
Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1Q24679555
Free radicals in the physiological control of cell functionQ27860480
Biochemistry and molecular cell biology of diabetic complicationsQ28131781
The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitusQ28190307
Oxidant stress and endothelial cell dysfunctionQ28609337
A molecular basis for insulin resistance. Elevated serine/threonine phosphorylation of IRS-1 and IRS-2 inhibits their binding to the juxtamembrane region of the insulin receptor and impairs their ability to undergo insulin-induced tyrosine phosphoryQ28645870
PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetesQ29547229
Obesity induces a phenotypic switch in adipose tissue macrophage polarizationQ29547686
Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetesQ29614548
Regulation of cardiac hypertrophy by intracellular signalling pathwaysQ29615166
Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damageQ29616101
Mitochondrial dysfunction and type 2 diabetesQ29617913
Regulation of endothelial constitutive nitric oxide synthase gene expression in endothelial cells and in vivo : a specific vascular action of insulin.Q54062879
Marked resistance of the ability of insulin to decrease arterial stiffness characterizes human obesity.Q54101101
Abdominal obesity: the most prevalent cause of the metabolic syndrome and related cardiometabolic riskQ54116903
Macrophage insulin receptor deficiency increases ER stress-induced apoptosis and necrotic core formation in advanced atherosclerotic lesions.Q54610885
Very-low-density lipoprotein response element in the promoter region of the human plasminogen activator inhibitor-1 gene implicated in the impaired fibrinolysis of hypertriglyceridemiaQ57607818
Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and managementQ58842177
Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarctionQ69973450
Perinatal hypothyroidism impairs the normal transition of GLUT4 and GLUT1 glucose transporters from fetal to neonatal levels in heart and brown adipose tissue. Evidence for tissue-specific regulation of GLUT4 expression by thyroid hormoneQ72272580
Treatment of hypertension in diabetesQ72678727
Hypertension in Diabetes Study (HDS): I. Prevalence of hypertension in newly presenting type 2 diabetic patients and the association with risk factors for cardiovascular and diabetic complicationsQ72967716
Synergistic effect of adrenal steroids and angiotensin II on plasminogen activator inhibitor-1 productionQ73351602
Insulin resistance and cardiovascular diseaseQ73397439
Microalbuminuria in Patients with Non-Insulin-dependent Diabetes Mellitus Relates to Nocturnal Systolic Blood PressureQ73498928
Lipoic acid reduces glycemia and increases muscle GLUT4 content in streptozotocin-diabetic ratsQ73515749
Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart diseaseQ73708513
Plasma levels of tissue plasminogen activator/plasminogen activator inhibitor-1 complex and von Willebrand factor are significant risk markers for recurrent myocardial infarction in the Stockholm Heart Epidemiology Program (SHEEP) studyQ74152600
Induction of hyperinsulinemia combined with hyperglycemia and hypertriglyceridemia increases plasminogen activator inhibitor 1 in blood in normal human subjectsQ74371090
Dyslipoproteinaemia and hyperoxidative stress in the pathogenesis of endothelial dysfunction in non-insulin dependent diabetes mellitus: an hypothesisQ77718606
Angiotensin II-mediated oxidative stress promotes myocardial tissue remodeling in the transgenic (mRen2) 27 Ren2 ratQ80171660
Metallothionein prevents high-fat diet induced cardiac contractile dysfunction: role of peroxisome proliferator activated receptor gamma coactivator 1alpha and mitochondrial biogenesisQ80491559
Vessel wall stiffness in type 1 diabetes and the central hemodynamic effects of acute hypoglycemiaQ80860389
Leptin induces mitochondrial superoxide production and monocyte chemoattractant protein-1 expression in aortic endothelial cells by increasing fatty acid oxidation via protein kinase AQ95721179
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy menQ29619308
Cellular mechanisms of insulin resistanceQ29619549
Mechanisms underlying endothelial dysfunction in diabetes mellitusQ31829307
Endothelial dysfunction as a target for prevention of cardiovascular diseaseQ33610670
Glucose-induced oxidative stress and programmed cell death in diabetic neuropathyQ33709276
Hypoglycemia, diabetes, and cardiovascular eventsQ33873251
Mitochondrial DNA instability and peri-implantation lethality associated with targeted disruption of nuclear respiratory factor 1 in miceQ33967022
Insulin resistance and cardiovascular diseaseQ34011027
Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistanceQ34577169
Mechanisms linking obesity with cardiovascular diseaseQ34590832
Severe hypoglycaemia and cardiovascular disease: systematic review and meta-analysis with bias analysisQ34881686
New Insights on Oxidative Stress and Diabetic Complications May Lead to a “Causal” Antioxidant TherapyQ35115544
Transcriptional regulatory circuits controlling mitochondrial biogenesis and functionQ35683727
Nuclear receptor signaling and cardiac energeticsQ35890852
Raising plasma fatty acid concentration induces increased biogenesis of mitochondria in skeletal muscle.Q35973475
Postprandial hyperglycemia and diabetes complications: is it time to treat?Q35992276
Ser/Thr phosphorylation of IRS proteins: a molecular basis for insulin resistanceQ36020413
Mechanisms of insulin resistance in humans and possible links with inflammationQ36095510
Insulin resistance: a metabolic pathway to chronic liver diseaseQ36297331
Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, PhQ36354637
Mitochondrial function, energy expenditure, aging and insulin resistance.Q36369803
Adipose tissue biology and cardiomyopathy: translational implicationsQ36496035
Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular systemQ36548154
High-fat diets cause insulin resistance despite an increase in muscle mitochondriaQ36693972
Oxidative stress in cardiovascular diseases and obesity: role of p66Shc and protein kinase C.Q36763396
Signalling to translation: how signal transduction pathways control the protein synthetic machineryQ36765810
Hypoglycemia and cardiovascular risksQ36783714
Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemiaQ36916418
Leptin signaling and obesity: cardiovascular consequencesQ36943073
Role of mitochondrial dysfunction in insulin resistanceQ37097807
Insulin signalling in the heartQ37129268
Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitusQ37350875
Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistanceQ37355863
Chronic hyperglycemia predisposes to exaggerated inflammatory response and leukocyte dysfunction in Akita mice.Q37415343
Diabetes and diabetes-associated lipid abnormalities have distinct effects on initiation and progression of atherosclerotic lesionsQ37486465
Peroxisome proliferator-activated receptor gamma coactivator-1 promotes cardiac mitochondrial biogenesisQ37526796
Skeletal muscle insulin resistance is the primary defect in type 2 diabetesQ37624257
Netrin-1 promotes adipose tissue macrophage retention and insulin resistance in obesity.Q37695058
Adaptive immunity in obesity and insulin resistanceQ38030832
Ectopic lipid storage and insulin resistance: a harmful relationshipQ38095619
Tumor necrosis factor-alpha suppresses adipocyte-specific genes and activates expression of preadipocyte genes in 3T3-L1 adipocytes: nuclear factor-kappaB activation by TNF-alpha is obligatoryQ38289787
Sp1 sites mediate activation of the plasminogen activator inhibitor-1 promoter by glucose in vascular smooth muscle cellsQ38338004
Genes are differentially expressed in the epididymal fat of rats rendered obese by a high-fat dietQ38358140
Mechanisms decreasing glucose oxidation in diabetes and starvation: role of lipid fuels and hormones.Q39567008
Insulin resistance of glucose uptake in skeletal muscle cannot be ameliorated by enhancing endothelium-dependent blood flow in obesityQ39800118
Macrophage-secreted factors induce adipocyte inflammation and insulin resistanceQ40326610
Endothelial function predicts future development of coronary artery disease: a study of women with chest pain and normal coronary angiogramsQ40511330
Role of insulin resistance and hyperinsulinemia in development of hypertension and atherosclerosis.Q40758368
Hypertension and associated metabolic abnormalities--the role of insulin resistance and the sympathoadrenal systemQ40933394
What's the RAGE? The receptor for advanced glycation end products (RAGE) and the dark side of glucoseQ41411365
Potential role of TNFalpha and lipoprotein lipase as candidate genes for obesityQ41581858
Glucose autoxidation and protein modification. The potential role of 'autoxidative glycosylation' in diabetesQ42098319
Insulin responsiveness of adipose tissue lipoprotein lipase is delayed but preserved in obesityQ42455941
Adipocyte lipases and defect of lipolysis in human obesityQ42485763
IRS1 degradation and increased serine phosphorylation cannot predict the degree of metabolic insulin resistance induced by oxidative stressQ42801707
Oxidative stress impairs nuclear proteins binding to the insulin responsive element in the GLUT4 promoterQ42819714
Oxidative stress induces insulin resistance by activating the nuclear factor-kappa B pathway and disrupting normal subcellular distribution of phosphatidylinositol 3-kinaseQ42829211
Relationship between blood pressure, plasma insulin and triglyceride concentration, and insulin action in spontaneous hypertensive and Wistar-Kyoto ratsQ43434828
Waist and hip circumferences have independent and opposite effects on cardiovascular disease risk factors: the Quebec Family StudyQ43643265
Depressed mitochondrial transcription factors and oxidative capacity in rat failing cardiac and skeletal muscles.Q44489944
Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities studyQ44493428
Vascular risk factors and markers of endothelial function as determinants of inflammatory markers in type 1 diabetes: the EURODIAB Prospective Complications StudyQ44495277
Adiponectin stimulates production of nitric oxide in vascular endothelial cells.Q44565932
Cardiac-specific induction of the transcriptional coactivator peroxisome proliferator-activated receptor gamma coactivator-1alpha promotes mitochondrial biogenesis and reversible cardiomyopathy in a developmental stage-dependent mannerQ44730585
Role of diabetes in congestive heart failure: the Framingham studyQ44758886
Risk factors for cardiac autonomic neuropathy in type 1 diabetes mellitusQ45201529
Insulin hypersecretion: a distinctive feature between essential and secondary hypertensionQ45937499
Additive beneficial effects of fenofibrate combined with atorvastatin in the treatment of combined hyperlipidemiaQ46489681
Resistance to Insulin-Stimulated-Glucose Uptake in Patients with Hypertension*Q46796524
Cardiac autonomic neuropathy predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathyQ47647645
Cardiovascular Complications in DiabeticsQ47984014
Insulin resistance as an independent risk factor for carotid wall thickening.Q51579378
Hyperinsulinemia as an independent risk factor for ischemic heart disease.Q51581884
High density lipoprotein (HDL) metabolism in noninsulin-dependent diabetes mellitus: measurement of HDL turnover using tritiated HDL.Q51628821
Relationship between plasma insulin levels and high density lipoprotein cholesterol levels in healthy men.Q51653341
Relationship of Glucose Tolerance and Plasma Insulin to the Incidence of Coronary Heart Disease: Results from Two Population Studies in FinlandQ51662797
Interactions between endothelin and nitric oxide in the regulation of vascular tone in obesity and diabetes.Q53890187
Obesity, insulin resistance, diabetes, and cardiovascular risk in children: an American Heart Association scientific statement from the Atherosclerosis, Hypertension, and Obesity in the Young Committee (Council on Cardiovascular Disease in the YoungQ53937437
Increasing plasma fatty acids elevates F2-isoprostanes in humans: implications for the cardiovascular risk factor cluster.Q53970280
P433issue1
P921main subjectcardiovascular diseaseQ389735
type 2 diabetesQ3025883
preproinsulinQ7240673
insulin resistanceQ1053470
risk factorQ1475848
P304page(s)11-23
P577publication date2015-11-05
P1433published inHeart Failure ReviewsQ2167497
P1476titleInsulin resistance: an additional risk factor in the pathogenesis of cardiovascular disease in type 2 diabetes
P478volume21

Reverse relations

cites work (P2860)
Q90055054A Novel Antidiabetic Monomers Combination Alleviates Insulin Resistance Through Bacteria-Cometabolism-Inflammation Responses
Q33879884A cross-sectional study on the associations of insulin resistance with sex hormone, abnormal lipid metabolism in T2DM and IGT patients
Q89863602Aberrant expression of miR-214 is associated with obesity-induced insulin resistance as a biomarker and therapeutic
Q55516148Actions of metformin and statins on lipid and glucose metabolism and possible benefit of combination therapy.
Q39803045Agrimonia eupatoria L. and Cynara cardunculus L. Water Infusions: Comparison of Anti-Diabetic Activities.
Q57488918An association of urinary sodium-potassium ratio with insulin resistance among Korean adults
Q46301239Association of insulin resistance and autonomic tone in patients with pregnancy-induced hypertension
Q59795787Baseline levels of serum high sensitivity C reactive protein and lipids in predicting the residual risk of cardiovascular events in Chinese population with stable coronary artery disease: a prospective cohort study
Q90370734Beneficial effects of cherry consumption as a dietary intervention for metabolic, hepatic and vascular complications in type 2 diabetic rats
Q38637752Cardiac transcriptome profiling of diabetic Akita mice using microarray and next generation sequencing
Q60920170Cdc42: A Novel Regulator of Insulin Secretion and Diabetes-Associated Diseases
Q91637063Diagnostic Accuracy of the Triglyceride and Glucose Index for Insulin Resistance: A Systematic Review
Q46452587Diallyl trisulfide exerts cardioprotection against myocardial ischemia-reperfusion injury in diabetic state, role of AMPK-mediated AKT/GSK-3β/HIF-1α activation
Q57289736Effect of Long-Term Exercise Training on lncRNAs Expression in the Vascular Injury of Insulin Resistance
Q33858997Effect of cholecystectomy on hepatic fat accumulation and insulin resistance in non-obese Hispanic patients: a pilot study.
Q92475946Efficacy of dapagliflozin versus sitagliptin on cardiometabolic risk factors in Japanese patients with type 2 diabetes: a prospective, randomized study (DIVERSITY-CVR)
Q61814801Expression of Notch-1 and nuclear factor-κB signal pathway in myocardial cells of coronary heart disease rats
Q38831748Heart selenoproteins status of metabolic syndrome-exposed pups: A potential target for attenuating cardiac damage
Q96132942Hypertension and Its Associated Factors Among Type 2 Diabetes Mellitus Patients at Debre Tabor General Hospital, Northwest Ethiopia
Q93161720International Union of Basic and Clinical Pharmacology. CVII. Structure and Pharmacology of the Apelin Receptor with a Recommendation that Elabela/Toddler Is a Second Endogenous Peptide Ligand
Q40155189Long-Term Efficacy and Safety of Insulin and Glucokinase Gene Therapy for Diabetes: 8-Year Follow-Up in Dogs
Q93015863Loss of Glycine N-Methyltransferase Associates with Angiopoietin-Like Protein 8 Expression in High Fat-Diet-Fed Mice
Q87789836Metabolic Syndrome Is Associated With Impaired Diastolic Function Independently of MRI-Derived Myocardial Extracellular Volume: The MESA Study
Q92579507Nanoformulations of natural products for management of metabolic syndrome
Q47548078Optimal cutoff for the evaluation of insulin resistance through triglyceride-glucose index: A cross-sectional study in a Venezuelan population
Q38845813Optimising the person-centred management of type 2 diabetes
Q61813610Plant-Derived Oleanolic Acid (OA) Ameliorates Risk Factors of Cardiovascular Diseases in a Diet-Induced Pre-Diabetic Rat Model: Effects on Selected Cardiovascular Risk Factors
Q97520357Potential roles of psychological and oxidative stress in insulin resistance: a cohort-based study
Q47578175Prevalence of Metabolic Syndrome and Its Individual Components Among Midwestern University Students
Q37078107Risk of skin cancer in patients with diabetes mellitus: A nationwide retrospective cohort study in Taiwan
Q49962054Sex-specific differences in insulin resistance in type 1 diabetes: The CACTI cohort
Q97520406Susceptibility to Hyperglycemia in Rats With Stress-Induced Depressive-Like Behavior: Involvement of IL-6 Mediated Glucose Homeostasis Signaling
Q47107979Swimming training alleviated insulin resistance through Wnt3a/β-catenin signaling in type 2 diabetic rats
Q42226832The Protective Effect of Antioxidants Consumption on Diabetes and Vascular Complications
Q91994816The Role of Protein Tyrosine Phosphatase (PTP)-1B in Cardiovascular Disease and Its Interplay with Insulin Resistance
Q50179864The relationship between obesity and cognitive health and decline
Q60948577Theaflavins Improve Insulin Sensitivity through Regulating Mitochondrial Biosynthesis in Palmitic Acid-Induced HepG2 Cells
Q99551783Therapeutic effect of metformin in the treatment of endometrial cancer
Q60044436To the editor regarding article "Coadministration of DPP-4 inhibitor and insulin therapy does not further reduce the risk of cardiovascular events compared with DPP-4 inhibitor therapy in diabetic foot patients: a nationwide population-based study"
Q50099869miR-214-Dependent Increase of PHLPP2 Levels Mediates the Impairment of Insulin-Stimulated Akt Activation in Mouse Aortic Endothelial Cells Exposed to Methylglyoxal.

Search more.